Videos

Paul discussed common symptoms and typical treatments for the 2 adverse events.

Sarnaik discussed several potential areas of innovation on the horizon.

Thomas Willemsen, president and chief executive officer, Tessa Therapeutics, discussed the company’s technologies and 2023 milestones.